IAC Express 2009 |
Issue number 839: December 7, 2009 |
|
Please click here to subscribe to IAC Express
as well as other FREE IAC periodicals. |
|
Contents
of this Issue
Select a title to jump to the article. |
- MMWR
Early Release reports on H1N1 influenza vaccine
safety
- ACIP posts provisional recommendations for use of HPV
vaccine
- CDC warns about email phishing scam related to H1N1
influenza vaccination
- CDC provides new H1N1 influenza vaccination information
for healthcare professionals
- Summary report of ACIP's October meeting is now online
- IAC's Video of the Week encourages kids to get vaccinated
- More translations available for seasonal and H1N1
influenza VISs
- Healthy Roads Media offers English-language H1N1
influenza VISs in alternative formats
- Important: While you're vaccinating against influenza, be
sure to administer PPSV to all people with existing
indications
- Laminated seasonal influenza vaccine pocket guides--FREE!--from the National Influenza Vaccine Summit
- Reminder: Abstracts for the 2010 National Immunization
Conference due by December 11
- November issue of CDC's Immunization Works electronic
newsletter recently released
- IAC updates "Quick Answers to Tough Questions" PowerPoint
presentation
- MMWR
reports on global measles mortality
- The
Measles Initiative launches redesigned website
- November issue of the Global Immunization News available
online
-
MMWR publishes information about Conference on Vaccine
Research
|
|
Abbreviations |
|
AAFP, American Academy of Family Physicians; AAP,
American Academy of Pediatrics; ACIP, Advisory Committee on Immunization
Practices; AMA, American Medical Association; CDC, Centers for Disease
Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD,
National Center for Immunization and Respiratory Diseases; NIVS, National
Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD,
vaccine-preventable disease; WHO, World Health Organization. |
|
Issue 839: December 7, 2009 |
|
|
1. |
MMWR Early Release reports on H1N1 influenza vaccine safety
On December 4, CDC published an MMWR Early
Release titled,
"Safety of Influenza A (H1N1) 2009 Monovalent Vaccines--United States, October 1-November 24, 2009." The first
paragraph is reprinted below.
The Food and Drug Administration (FDA) licensed the first
2009 influenza A (H1N1) monovalent vaccines ("H1N1
vaccines") on September 15, 2009. The H1N1 vaccines are
available as a live, attenuated monovalent vaccine (LAMV)
for intranasal administration and as monovalent,
inactivated, split-virus or subunit vaccines for injection
(MIV). The licensure and manufacturing processes for the
monovalent H1N1 vaccines were the same as those used for
seasonal trivalent inactivated (TIV) or trivalent live,
attenuated influenza vaccine (LAIV); none of these vaccines
contains an adjuvant. Vaccine safety monitoring is an
important component of all vaccination programs. To assess
the safety profile of H1N1 vaccines in the United States,
CDC reviewed vaccine safety results for the H1N1 vaccines
from 3,783 reports received through the U.S. Vaccine Adverse
Event Reporting System (VAERS) and electronic data from
438,376 persons vaccinated in managed-care organizations in
the Vaccine Safety Datalink (VSD), a large, population-based
database with administrative and diagnostic data, in the
first 2 months of reporting (as of November 24). VAERS data
indicated 82 adverse event reports per 1 million H1N1
vaccine doses distributed, compared with 47 reports per 1
million seasonal influenza vaccine doses distributed.
However, no substantial differences between H1N1 and
seasonal influenza vaccines were noted in the proportion or
types of serious adverse events reported. No increase in any
adverse events under surveillance has been seen in VSD data.
Many agencies are using multiple systems to monitor H1N1
vaccine safety. Healthcare providers and the public are
encouraged to report adverse health events that occur after
vaccination. . . .
To access the complete Early Release in web-text (HTML)
format, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm58e1204a1.htm?s_cid=mm58e1204a1_e
Back to top |
|
|
2. |
ACIP posts provisional recommendations for use of HPV vaccine
On December 1, CDC posted provisional
recommendations for
use of HPV vaccine on the ACIP web section. Provisional
recommendations are those ACIP has voted on but that are not
yet approved by CDC or the Department of Health and Human
Services and have not yet been published in MMWR. A portion
of the HPV provisional recommendations is reprinted below.
On October 21, 2009, ACIP voted on updated recommendations
for use of human papillomavirus (HPV) vaccine, including
recommendations for the bivalent HPV (types 16 and 18)
vaccine (Cervarix) for females and the quadrivalent HPV
(types 6, 11, 16 and 18) vaccine (Gardasil) for females and
males.
These recommendations, when published in the MMWR, will
replace recommendations published in the 2007 MMWR
Recommendations and Reports document: Centers for Disease
Control and Prevention. Quadrivalent Human Papillomavirus
Vaccine: Recommendations of the Advisory Committee on
Immunization Practices (ACIP). MMWR 2007; 56(No. RR-02).
PROVISIONAL RECOMMENDATIONS FOR FEMALES
ACIP recommends routine vaccination of females aged 11 or 12
years with 3 doses of HPV vaccine. The vaccination series
can be started as young as age 9 years.
HPV vaccination also is recommended for females aged 13
through 26 years who have not been previously vaccinated or
who have not completed the full vaccination series. Ideally,
vaccine should be administered before potential exposure to
HPV through sexual contact.
- ACIP recommends vaccination with either the bivalent HPV
vaccine or the quadrivalent vaccine for prevention of
cervical cancers and precancers.
- ACIP recommends vaccination with the quadrivalent HPV
vaccine for prevention of cervical cancers and precancers,
and genital warts.* [FOOTNOTE] The quadrivalent vaccine
has also been demonstrated to protect against vulvar and
vaginal cancers and precancers.
PROVISIONAL RECOMMENDATIONS FOR MALES
The 3-dose series of quadrivalent HPV vaccine may be given
to males aged 9 through 26 years to reduce their likelihood
of acquiring genital warts. Ideally, vaccine should be
administered before potential exposure to HPV through sexual
contact.
These provisional recommendations also provide guidance
related to HPV administration, precautions, and
contraindications.
To access the complete HPV provisional recommendations, go
to:
http://www.cdc.gov/vaccines/recs/provisional/downloads/hpv-vac-dec2009-508.pdf
All provisional ACIP recommendations can be found at
http://www.cdc.gov/vaccines/recs/provisional
To access all final ACIP recommendations, go to:
http://www.immunize.org/acip IAC's ACIP web section allows
visitors to sort documents by date, vaccine, or topic.
Bookmark this link for easy access to all provisional and
final ACIP recommendations.
Back to top |
|
|
3. |
CDC warns about email phishing scam related to H1N1 influenza vaccination
CDC has received reports of fraudulent emails
asking users
to register their vaccination profile with the government. A
statement from CDC about this phishing scam follows.
CDC has received reports of fraudulent emails (phishing)
referencing a CDC sponsored State Vaccination Program.
The messages request that users must create a personal H1N1
(swine flu) Vaccination Profile on the cdc.gov website. The
message then states that anyone that has reached the age of
18 has to have his/her personal Vaccination Profile on the
cdc.gov site.
The CDC has NOT implemented a state vaccination program
requiring registration on www.cdc.gov Users that click on
the email are at risk of having malicious code installed on
their system. CDC reminds users to take the following steps
to reduce the risk of being a victim of a phishing attack:
- Do not follow unsolicited links and do not open or respond
to unsolicited email messages.
- Use caution when visiting un-trusted websites.
- Use caution when entering personal information online.
CDC has published this warning with a replica of an actual
phishing email at http://www.cdc.gov/hoaxes_rumors.html
Back to top |
|
|
4. |
CDC provides new H1N1 influenza vaccination information for healthcare
professionals
CDC continually updates information about H1N1
influenza
vaccination on its website and through email notices. On
December 2, CDC informed its partners that 70.2 million
doses of 2009 H1N1 influenza vaccine had been made
available, with approximately 24% of the doses being the
live, nasal-spray vaccine.
CDC experts have also noted that although H1N1 influenza
disease is declining, the virus is far from gone.
Vaccination is the best prevention against the 2009 H1N1
virus, and the lull in disease activity provides a window of
opportunity for vaccinating susceptible people.
In addition, CDC recently added or updated the following
resources for healthcare professionals on its H1N1 web
section:
2009 H1N1 Influenza: Resources for Pharmacists
http://www.cdc.gov/h1n1flu/pharmacist
Questions and Answers on 2009 H1N1 Vaccine Financing
http://www.cdc.gov/H1N1flu/vaccination/statelocal/vaccine_financing.htm
Interim Guidance for Management of Influenza-Like Illness
aboard Commercial Aircraft during the 2009-10 Influenza
Season
http://www.cdc.gov/h1n1flu/guidance/air-crew-dom-intl.htm
Preparing for the Flu: A Communication Toolkit for Schools
(Grades K-12)
http://www.cdc.gov/h1n1flu/schools/toolkit
Opening and Mixing Tamiflu Capsules with Liquids if Child
Cannot Swallow Capsules [for caregivers]
http://www.cdc.gov/h1n1flu/antivirals/mixing_tamiflu_qa.htm
Fraudulent Emails Referencing CDC-Sponsored State
Vaccination Program
http://www.cdc.gov/hoaxes_rumors.html
CDC's H1N1 Flu web section contains hundreds of documents
for healthcare professionals and the public. To access the
web section's home page, go to: http://www.cdc.gov/h1n1flu
To make it easy for you to keep up to date with
developments, IAC has gathered important information related
to H1N1 influenza into a single web section. To access this
resource, go to: http://www.immunize.org/h1n1
Back to top |
|
|
5. |
Summary report of ACIP's October meeting is now online
[The following is cross posted from CDC's
Immunization Works
electronic newsletter, November 2009.]
ACIP HIGHLIGHTS
The Advisory Committee on Immunization Practices (ACIP) held
its final meeting for 2009 in Atlanta October 21 and 22. The
meeting produced several new and updated recommendations.
These recommendations are provisional until they are
reviewed by the director of CDC and published in the MMWR.
Full minutes of the meeting, including slides from
presentations, will be available soon on the ACIP Meetings
web page.
Topics addressed at this meeting were
HPV
-
The committee voted to update the human papillomavirus
(HPV) vaccine recommendations to include the recently
licensed bivalent vaccine for women.
-
They voted to harmonize the schedule and dosing
recommendations for the two vaccines (for women) without
expressing a preference for either vaccine, to update the
precautions and contraindications to apply to both vaccines.
-
The committee also voted to add a permissive
recommendation for males 9 through 26 years of age to
receive the quadrivalent HPV vaccine to prevent genital
warts.
SCHEDULES
The committee voted to approve the 2010 vaccine schedules
both for children and adolescents and for adults. Each will
contain minor changes and updates from the previous year's
edition.
GENERAL RECOMMENDATIONS
After discussing the incorporation into the General
Recommendations of previously free-standing, but non-vaccine
specific, ACIP statements on Adolescent and Adult
Vaccination Principles, the General Recommendations Work
Group summarized revisions to the document. These include
small changes to the sections on combination vaccines,
timing and spacing, storage and handling, and syncope. The
committee voted to accept the final document with the
understanding that several outstanding issues, e.g.,
vaccination of persons with altered immunocompetence, will
be resolved prior to publication.
YELLOW FEVER
The committee voted to approve an updated yellow fever
statement in light of evolving epidemiologic and adverse
event data. Changes will affect indications,
contraindications and precautions, and the vaccine's adverse
event profile.
PNEUMOCOCCAL
The committee reviewed epidemiologic data regarding invasive
pneumococcal disease in children, heard immunogenicity and
cost-effectiveness data on the forthcoming 13-valent
pneumococcal conjugate vaccine, and discussed proposed
recommendations for incorporating it into the routine and
catch-up childhood schedules.
The committee discussed the use of meningococcal conjugate
vaccines, including proposed combination vaccines, in
infants; heard an update on rotavirus vaccine and post-licensure monitoring of intussusception; got the initial
report from the new RSV work group; and heard updates on the
vaccine supply and influenza and influenza vaccine. CDC,
CMS, DoD, DVA, FDA, HRSA, HIS, NIH, NVAC and NVPO provided
agency updates, and there were a number of public comments,
mainly regarding HPV vaccine.
Back to top |
|
|
6. |
IAC's Video of the Week encourages kids to get vaccinated
This week, IAC's Video of the Week section
includes a 28-minute episode from the PBS animated series "Sid the Science
Kid" that deals with getting an influenza vaccine, as well
as a 2-minute song from the show. The episode is titled,
"Getting a Shot: You can do it!"
The video will be available on the home page of IAC's
website through December 13. To access it, go to:
http://www.immunize.org and click on the image under the
words Video of the Week. It may take a few moments for the
video to begin playing; please be patient!
Remember to bookmark IAC's home page to view a new video
every Monday. To view an IAC Video of the Week from the
past, go to the video archive at http://www.immunize.org/votw
Back to top |
|
|
7. |
More translations available for seasonal and H1N1 influenza VISs
The VISs for 2009 H1N1 inactivated influenza
vaccine
(injectable) and 2009 H1N1 live attenuated influenza vaccine
(nasal spray) are now available in Dinka (spoken in Sudan),
Kirundi (spoken in Burundi), Kunama (spoken in Eritrea),
Punjabi (spoken in India and Pakistan), and Tigrigna (spoken
in Ethiopia). IAC gratefully acknowledges the California
Department of Public Health, Immunization Branch, for the
translations.
The VIS for the seasonal inactivated influenza vaccine
(injectable) is now available in Amharic (spoken in
Ethiopia). IAC gratefully acknowledges the Minnesota
Department of Health and the DSMA Ethiopian Orthodox
Tewahedo Church Parish Nursing Program, Minneapolis, MN, for
the translation.
To access the new translations (Dinka, Kirundi, Kunama,
Punjabi, and Tigrigna) of the VIS for the injectable 2009
H1N1 influenza vaccine, as well as this VIS in English and
other translations, go to: http://www.immunize.org/vis/vis_h1n1_inactive.asp Click on
the pertinent languages.
To access the new translations (Dinka, Kirundi, Kunama,
Punjabi, and Tigrigna) of the VIS for the nasal-spray 2009
H1N1 influenza vaccine, as well as this VIS in English and
other translations, go to: http://www.immunize.org/vis/vis_h1n1_live.asp Click on the
pertinent languages.
To access the new Amharic translation of the VIS for the
seasonal inactivated influenza vaccine, as well as the VIS
in English and other translations, go to:
http://www.immunize.org/vis/vis_flu_inactive.asp
For information about the use of VISs, and for VISs in more
than 35 languages, visit IAC's VIS web section at
http://www.immunize.org/vis
For general information about VISs from CDC's website go to:
http://www.cdc.gov/vaccines/pubs/vis
Back to top |
|
|
8. |
Healthy Roads Media offers English-language H1N1 influenza VISs in alternative
formats
Healthy Roads Media has posted the
English-language H1N1
influenza VISs in alternative formats, including one (MPEG
video format) that can be used in closed-circuit television
or video-on-demand systems.
To access the free MPEG video versions of the H1N1 influenza
VISs, go to:
http://www.healthyroadsmedia.org/videos/agree.htm
To access the H1N1 influenza VIS in other alternative
formats (audio, mobile video, multimedia), as well as
Healthy Roads Media's other immunization resources, go to:
http://www.healthyroadsmedia.org/topics/immunization.htm
Back to top |
|
|
9. |
Important: While you're vaccinating against influenza, be sure to administer
PPSV to all people with existing indications
CDC advises healthcare professionals that during
seasonal and H1N1 influenza outbreaks, all people who have existing
indications for pneumococcal polysaccharide vaccine (PPSV) should be
vaccinated according to current ACIP recommendations. This is important
because people with existing indications are not only at increased risk for
pneumococcal disease, but are also at increased risk for serious
complications from influenza.
CDC has issued related guidance titled "Prevention of Pneumococcal Infections
Secondary to Seasonal and 2009 H1N1 Influenza Virus Infection." To access it,
go to:
http://www.cdc.gov/h1n1flu/vaccination/provider/provider_pneumococcal.htm
Back to top |
|
|
10. |
Laminated seasonal influenza vaccine pocket guides--FREE!--from the National
Influenza Vaccine Summit
With vaccination against 2009 H1N1 influenza now
underway,
it is important to remember that seasonal influenza
vaccination efforts must continue. To aid in these efforts,
the Immunization Action Coalition is inviting IAC Express
readers to place orders now for the National Influenza
Vaccine Summit's laminated 2009-10 Seasonal Influenza
Vaccination Pocket Information Guides. The pocket guides are
the perfect size to fit in a lab coat pocket. And best of
all--they're free!
See an image of the laminated seasonal influenza vaccine
pocket guide at
http://www.preventinfluenza.org/fluguide/pocketguide_flu.pdf
For description of the content of the pocket guides and
information on their background, go to:
http://www.immunize.org/express/issue833.asp#n16
The Summit is also pleased to be able to offer a companion
piece to the laminated influenza pocket guides--free
laminated pocket guides for the administration of
pneumococcal polysaccharide vaccine (PPSV). See an image of
the PPSV pocket guide at
http://www.immunize.org/ppvguide/pocketguide.pdf
HOW TO ORDER
Each order must be for a minimum of 100 pocket guides. Place
your order at http://www.preventinfluenza.org/pocketguides
There is no cost for the pocket guides, shipping, or
handling within the U.S.
If you have questions, email admininfo@immunize.org
Back to top |
|
|
11. |
Reminder: Abstracts for the 2010
National Immunization Conference due by December 11rticle 11.
If you plan on submitting an abstract for CDC's
2010
National Immunization Conference, be aware that the deadline
is December 11. The conference will take place April 19-22,
in Atlanta, GA.
On December 3, CDC published a special edition of
Immunization Works, encouraging people to submit abstracts
appropriate for the health and risk communication track of
the conference. The text of this communication follows.
Call for Health and Risk Communication Abstracts
Deadline for submission is December 11, 2009
The Centers for Disease Control and Prevention is pleased to
announce the 44th Annual National Immunization Conference.
The goals of this conference are to disseminate information
and to explore innovative strategies for developing
programs, policy, and research to promote comprehensive
immunization coverage for all age groups.
We invite you to submit an abstract for the Health and Risk
Communication Track. This track includes presentations
focusing on risk communication strategies, addressing
vaccine hesitancy, and building effective media campaigns
and collaborations. Abstracts may describe communication
programs or pilot projects, innovative research methods and
risk communication practices, methods for evaluating
communication effectiveness, and media engagement.
Abstract submissions may be related to, but are not limited
to the following areas:
- Social/new media
- Audience research and segmentation
- Web communication strategies
- Innovations in immunization communication
- Evaluating communication campaigns and evaluation metrics
- Health literacy/plain language communication
- Best practices in working with the media
- Message development
- Partnerships for vaccine communication
- Communication channel selection (i.e. traditional media
vs. social media)
- Modeling and modifying behaviors
For more information about abstract submissions, please
visit http://cdc.confex.com/cdc/nic2010/cfp.cgi
For more information about the conference, please visit:
http://www.cdc.gov/vaccines/events/nic
Remember to register for the conference before February 19
to get the early-bird rate. To register online, go to:
http://conferences.taskforce.org/nic10
For additional information, contact the conference planning
team at (404) 639-8225 or nipnic@cdc.gov
Back to top |
|
|
12. |
November issue of CDC's Immunization Works electronic newsletter recently
released
CDC recently released the November issue of its
monthly
newsletter Immunization Works; it is posted on the website
of the National Center for Immunization and Respiratory
Diseases (NCIRD). The newsletter offers the immunization
community information about current topics. The information
is in the public domain and can be reproduced and circulated
widely.
Most of the information in the November issue has already
appeared in previous issues, or the current issue, of IAC
Express. Here are two articles not covered elsewhere:
STAY INFORMED
Stay Informed! Information on 2009 pandemic influenza A
(H1N1) is updated frequently. Please visit the following
websites for the latest updates:
CDC PODCASTS
CDC has released several podcasts this month including "H1N1
Flu Vaccine--Why the Delay," "Influenza Round Table: Warning
Signs," and "Influenza Round Table: Don't Get, Don't
Spread." Each podcast is approximately 2 to 4 minutes long
and there are more than 300 different podcasts in 20
different series covering a wide range of health topics.
Access CDC podcasts on your computer or download them for
reliable health and safety information.
(http://www2c.cdc.gov/podcasts)
To access the complete November issue from CDC's Vaccines &
Immunizations website, go to:
http://www.cdc.gov/vaccines/news/newsltrs/imwrks/2009/200911.htm
Back to top |
|
|
13. |
IAC updates "Quick Answers to Tough Questions" PowerPoint presentation
In 2005, IAC consultant Teresa Anderson, DDS,
MPH, presented
a workshop talk titled "Quick Answers to Tough Questions" at
the National Immunization Conference. The presentation
provided healthcare professionals with basic talking points
and resources to use with vaccine-hesitant parents and
patients. The presentation has been updated to include
discussion of current controversies such as alternative
schedules and vaccine adjuvants.
Feel free to use this information as needed. The
Immunization Action Coalition is pleased when others reprint
or adapt our materials. If you adapt our material for your
organization or personal use, please acknowledge the
Immunization Action Coalition as the source.
Back to top |
|
|
14. |
MMWR reports on global measles mortality
CDC published "Global Measles Mortality,
2000-2008" in the
December 4 issue of MMWR. The first paragraph of the
Editorial Note follows.
After a period of rapid progress in reducing global measles
mortality during 2000-2006, the reduction in measles
mortality has begun to level off, raising the possibility
that the 2010 goal might not be reached. Approximately 77%
of the estimated global measles mortality in 2008 was
concentrated in one region (SEAR [South-East Asia Region]).
Further progress toward the 90% mortality reduction goal is
impeded by two factors: (1) India has not fully implemented
the measles mortality strategies recommended by WHO and
UNICEF in 2001, and (2) political and financial commitment
to sustaining measles control in many of the other 46
priority countries has declined. . . .
To access the full article in web-text (HTML) format, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5847a2.htm
Back to top |
|
|
15. |
The
Measles Initiative launches redesigned website
[The following is cross posted from CDC's
Immunization Works
electronic newsletter, November 2009.]
RELAUNCH OF THE MEASLES INITIATIVE
The Measles Initiative is a partnership committed to
reducing measles deaths globally. Launched in 2001, the
Measles Initiative--led by the American Red Cross, the
United Nations Foundation, the U.S. Centers for Disease
Control and Prevention, UNICEF and the World Health
Organization--provides technical and financial support to
governments and communities conducting mass vaccination
campaigns, improving routine immunization services, and
establishing effective disease surveillance. After more than
a year's worth of work, the Measles Initiative has re-launched a new website design that features improved
navigation, enhanced internal search engine capabilities, a
comprehensive multimedia library and interactive map. A
substantial amount of updated content has also been added to
better showcase this public health partnership's work around
the world. Visit the Measles Initiative website
(http://www.measlesinitiative.org) to learn how the Measles
Initiative is helping reduce global measles deaths as well
as to access journal articles, presentations and campaign
reports.
Back to top |
|
|
16. |
November issue of the Global Immunization News available online
The November 30, 2009, issue of WHO's Global
Immunization
News can be accessed online at
http://www.who.int/immunization/GIN_November_2009.pdf
Older issues of the Global Immunization News are archived at
http://www.who.int/immunization/gin/en
Back to top |
|
|
17. |
MMWR publishes information about Conference on Vaccine Research
CDC published "Announcement: 13th Annual
Conference on
Vaccine Research" in the December 4 issue of MMWR. The first
paragraph follows.
The Thirteenth Annual Conference on Vaccine Research, the
largest scientific forum devoted exclusively to the research
and development of vaccines and related technologies for
prevention and treatment of disease through immunization,
will be held April 26-28, 2010, at the Bethesda North
Marriott & Conference Center Hotel in Bethesda, Maryland.
The conference brings together the diverse fields of human
and veterinary vaccinology to encourage collaboration and
multidisciplinary approaches among disease-specific and
methodologic experts.
For more details about the conference, including information
about abstract submission, travel grants, and the Maurice R.
Hilleman Early-State Career Investigator Award, go to:
http://www.nfid.org/conferences/vaccine10 or contact the
conference planners at (301) 656-0003 or vaccine@nfid.org
To access the full article in web-text (HTML) format, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5847a4.htm
Back to top |
|
|
|